The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
Vazquez-Martin, A., Oliveras-Ferraros, C., del Barco, S., Martin-Castillo, B., Menendez, J. A.Volume:
20
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdn758
Date:
October, 2008
File:
PDF, 300 KB
english, 2008